Peter Kao, MD., PhD.
Associate Professor, Division of Pulmonary, Allergy & Critical Care Medicine
Dr. Kao, received his MD and PhD degrees from Columbia University College of Physicians and Surgeons. He established rodent models of inflammatory pulmonary hypertension and demonstrated that the endothelial lineage contributes to the neointimal vascular occlusion. Additionally, Dr. Kao discovered and cloned novel gene regulators NF45/ILF2 and NF90/ILF3 that modulate chromatin conformation, RNA transcription, RNA splicing and translation. These host cell factors are hijacked during viral infections to support viral replication and gene expression. Dr. Kao is exploring novel antiviral strategies based on his unique insights into the biology of ILF2 and ILF3.
View CAP Profile >>
Email: peterkao@stanford.edu